Last checked at 30 Jul 2021 09:50
BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda
BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News2
GSK Share
Chat2
GSK Share
Trades1,918
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,652.50
Bid:
1,652.00
Ask:
1,653.00
Change:
1.50 (0.09%)
Spread:
1.00 (0.061%)
Open:
1,656.50
High:
1,661.50
Low:
1,650.00
Prev. Close:
1,651.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.29 Jul 2021 22:08
TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
Read more29 Jul 2021 10:36
BROKER RATINGS: Citi resumes Melrose at Buy; Peel cuts Pets At Home
BROKER RATINGS: Citi resumes Melrose at Buy; Peel cuts Pets At Home
Read more28 Jul 2021 12:44
TOP NEWS: GSK retains guidance despite weaker interim results
TOP NEWS: GSK retains guidance despite weaker interim results
Read more28 Jul 2021 12:32
GSK and Vir Biotechnology to supply EU with Covid-19 treatment
(Sharecast News) - GlaxoSmithKline has inked a joint procurement deal with Brussels for its Covid-19 treatment Sotrovimab together with its partner Vir Biotechnology.
Read more28 Jul 2021 12:20
LONDON MARKET MIDDAY: Travel and banking stocks lead gains before Fed
LONDON MARKET MIDDAY: Travel and banking stocks lead gains before Fed
Read more28 Jul 2021 12:14
UPDATE 3-GSK more upbeat on profits and COVID, investors not sure
* Q2 adjusted EPS 28.1 pence vs consensus 19.9 pence* Sees FY adj EPS at better end of guidance range* Progress with COVID-19 adjuvant, antibody treatment (Writes through with CEO, analyst comment, detail)By Pushkala Aripaka and Alistair SmoutJuly 2...
Read more28 Jul 2021 12:14
UPDATE 2-GSK sees smaller 2021 profit fall after Q2 beat
* Q2 adjusted EPS 28.1 pence vs forecast 19.9 pence* Sees FY adj EPS at better end of guidance range (Adds more detail, background, shares)By Pushkala AripakaJuly 28 (Reuters) - GSK forecast a smaller drop in 2021 profit on Wednesday as the drugmak...
Read more28 Jul 2021 12:14
UPDATE 1-GSK sees smaller 2021 profit fall after Q2 beat
(Adds detail, background)July 28 (Reuters) - GSK forecast a smaller drop in 2021 profit on Wednesday as the drugmaker beat second-quarter earnings expectations, buoyed by a pick up at its vaccines business as routine hospital visits recovered amid...
Read more28 Jul 2021 12:09
GlaxoSmithKline Q2 profits, revenue jump
(Sharecast News) - GlaxoSmithKline said on Wednesday that it expects full-year earnings to be towards the top end of its guidance range as it reported a jump in second-quarter profit and revenues amid a recovery in the vaccines business.
Read more28 Jul 2021 12:07
GSK sees smaller 2021 profit fall after Q2 beat
July 28 (Reuters) - GSK forecast a smaller drop in 2021 profit on Wednesday, as the drugmaker topped analysts' expectations for second-quarter profit after a pick-up in hospital visits following easing of COVID-19 restrictions boosted its vaccine...
Read more28 Jul 2021 11:47
UPDATE 1-EU signs deal with GSK for supply of potential COVID drug
(adds GSK comment, details)BRUSSELS, July 28 (Reuters) - The European Union has signed a contract with GlaxoSmithKline for the supply of up to 220,000 treatments of its investigational monoclonal antibody therapy sotrovimab against COVID-19, it sa...
Read more28 Jul 2021 11:47
UPDATE 2-EU signs deal with GSK for supply of potential COVID drug
(Adds background)BRUSSELS, July 28 (Reuters) - The European Union has signed a contract with GlaxoSmithKline for the supply of up to 220,000 treatments of its investigational monoclonal antibody therapy sotrovimab against COVID-19, it said on Wedn...
Read more28 Jul 2021 11:06
EU signs deal with GSK for supply of COVID potential drug
BRUSSELS, July 28 (Reuters) - The European Union has signed a contract with GlaxoSmithKline for the supply of up to 220,000 treatments of its investigational monoclonal antibody therapy sotrovimab against COVID-19, it said on Wednesday.The contrac...
Read more26 Jul 2021 16:53
CORRECTED-UPDATE 1-BioNTech aims to develop mRNA-based malaria vaccine
(Corrects mRNA description in paragraph 6 to pathogen from virus)* Plans to start clinical trial by end of 2022* Malaria kills more than 400,000 people per year* BioNTech explores vaccine production in AfricaBERLIN, July 26 (Reuters) - BioNTech want...
Read more